Rehmann Capital Advisory Group
Source: SEC Form 13F · as of Mar 2026Rehmann Capital Advisory Group holds 28 biotech & pharma companies tracked by BioSniper, totaling $50.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
28
Total value held
$50.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 38,637 | $9.4M |
| LLYELI LILLY & Co | 5,059 | $4.7M |
| PFEPFIZER INC | 161,403 | $4.5M |
| MRKMerck & Co., Inc. | 29,158 | $3.5M |
| ABBVAbbVie Inc. | 12,668 | $2.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,838 | $2.7M |
| MCKMcKesson Corporation | 2,873 | $2.5M |
| BMYBRISTOL MYERS SQUIBB CO | 40,251 | $2.4M |
| AMGNAMGEN INC | 5,876 | $2.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 2,393 | $1.8M |
| PMPhilip Morris International Inc | 10,810 | $1.8M |
| UTHRUNITED THERAPEUTICS Corp | 2,957 | $1.8M |
| GILDGILEAD SCIENCES, INC. | 11,650 | $1.6M |
| AZNASTRAZENECA PLC | 7,001 | $1.4M |
| ELVElevance Health Inc. | 4,219 | $1.2M |
| ABTABBOTT LABORATORIES | 12,066 | $1.2M |
| NVSNovartis AG | 6,697 | $1.0M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,039 | $910K |
| CORCencora Inc. | 2,325 | $730K |
| NVONovo Nordisk A/S | 16,188 | $595K |
| CAHCardinal Health Inc. | 2,361 | $499K |
| IQVIQVIA Holdings Inc. | 2,531 | $431K |
| QGENQIAGEN N.V. | 9,909 | $397K |
| SNYSanofi | 6,381 | $307K |
| GMOptec International, Inc. | 3,993 | $298K |
| BIIBBIOGEN INC. | 1,165 | $214K |
| BCRXBIOCRYST PHARMACEUTICALS INC | 10,041 | $96K |
| JSPRJasper Therapeutics Inc. | 15,300 | $13K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.